Tissue Regeneration Equipment Supplied In France
6 equipment items found
Manufactured by:HTL Biotechnology based inJavene, FRANCE
HTL provides HighlyPolyDeoxyRibonucleotides (HDPR), also known as Integral DNA. HTL provides Integral DNA in injectable grade, suitable for medica applications. HTL extracts this API from a renewable animal resource. The gentle production process of integral DNA is designed to protect the double strand structure of DNA and ensure a very high level of purity. The average molecular weight of the ...
Manufactured by:Meccellis Biotech based inLa Rochelle, FRANCE
CELLIS® Dental is a cell-free, non-pyrogenic collagen matrix (acellular dermal matrix ADM) obtained from porcine skin. CELLIS® Dental is intended for use as a surgical membrane in soft tissue repairs and serves to support, cover or replace ...
by:Cap Actuel based inParis, FRANCE
DualSonic is a portable HIFU aesthetic device specially designed for professional or home facial treatment. Effective, practical, precise, safe, the modular device improves skin quality, reduces wrinkles, lifts and reshapes by acting on the different skin layers including the SMAS. With high intensity focused ultrasound you get a more perfect and elastic ...
Manufactured by:SYMATESE based inCHAPONOST, FRANCE
NEVELIA® dermal regeneration template is used to reconstruct the dermis following a skin loss. NEVELIA® dermal regeneration template is used to reconstruct the dermis following a skin loss. NEVELIA® dermal regeneration template is a sterile medical device consisting of a collagen layer to promote dermal regeneration and a reinforced silicone layer acting as a pseudo-epidermis. ...
Manufactured by:Lattice Medical based inLoos, FRANCE
Lattice Medical is a biomedical start-up that was launched in October 2017; Patented 3D technology developed with CHU Lille-France that allows adipose tissue to naturally ...
Manufactured by:CellProthera based inMulhouse, FRANCE
The unique therapeutic approach proposed by CellProthera is protected by various patents. It requires a simple blood sampling best performed within 2 weeks following a severe AMI. The sampling occurs after a treatment period using GCSF in order to mobilize the patient’s own stem cells into the blood flow. The patient’s blood sample is then forwarded to a local certified Cell Therapy ...